ZipBio

ZipBio

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.ziptx.bio

Last Round

Seed

Sep 5, 2024

Total Funding Raised

$4M

Momentum Score

25 /100

Company Overview

ZipBio is a biotechnology company focused on developing gene therapies and biologics, leveraging generative AI to create innovative therapeutics that address critical unmet medical needs by simplifying complex functions into efficient therapeutic molecules.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

AI drug discoverygenerative biologyde novo protein designprotein compressiongene therapygenerative AI platformin silico drug designcomputational biologynovel therapeuticspharma partnershipsde novo gene designophthalmology therapeuticspan-VEGF inhibitordrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZipBio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ZipBio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 5, 2024

Key People

Founding team and executive leadership

Ori Zelichov

Co-Founder, President Chief Medical Officer

Founding Team

Roee Farber

Co-Founder CEO

Founding Team

ZipBio Investors

Notable investors and investment history

InvestorRounds
NFXSeed
MoreVCSeed

ZipBio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ZipBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ZipBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range7
Year Founded2022
Last FundingSep 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.